231 related articles for article (PubMed ID: 9110291)
1. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.
Prayson RA
Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291
[TBL] [Abstract][Full Text] [Related]
2. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
Prayson RA; Mohan DS; Song P; Suh JH
Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
Prayson RA
Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
[TBL] [Abstract][Full Text] [Related]
5. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
6. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
Miyagami M; Nakamura S
No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
[TBL] [Abstract][Full Text] [Related]
7. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
8. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases.
Santi M; Mena H; Wong K; Koeller K; Olsen C; Rushing EJ
Cancer; 2003 Aug; 98(3):554-61. PubMed ID: 12879473
[TBL] [Abstract][Full Text] [Related]
9. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis.
Gyure KA; Prayson RA
Mod Pathol; 1997 Apr; 10(4):313-7. PubMed ID: 9110292
[TBL] [Abstract][Full Text] [Related]
10. Spinal myxopapillary ependymoma: neurological deterioration in patients treated with surgery.
Sakai Y; Matsuyama Y; Katayama Y; Imagama S; Ito Z; Wakao N; Kanemura T; Yoshida G; Sato K; Ando T; Nakamura H; Kato F; Yukawa Y; Ito K; Ishiguro N
Spine (Phila Pa 1976); 2009 Jul; 34(15):1619-24. PubMed ID: 19564773
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic pleomorphic xanthoastrocytoma.
Prayson RA; Morris HH
Arch Pathol Lab Med; 1998 Dec; 122(12):1082-6. PubMed ID: 9870856
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R
Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722
[TBL] [Abstract][Full Text] [Related]
13. Long-term surgical outcomes for myxopapillary ependymomas of the cauda equina.
Nakamura M; Ishii K; Watanabe K; Tsuji T; Matsumoto M; Toyama Y; Chiba K
Spine (Phila Pa 1976); 2009 Oct; 34(21):E756-60. PubMed ID: 19934795
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic results of eight patients with intracranial ependymomas].
Sasajima T; Takahashi M; Kinouchi H; Suzuki A; Mizoi K
No To Shinkei; 2003 Mar; 55(3):233-40. PubMed ID: 12728504
[TBL] [Abstract][Full Text] [Related]
15. Significance of MIB-1, PCNA indices, and p53 protein over-expression in intramedullary tumors of the spinal cord.
Iwata K; Nakagawa H; Hashizume Y
Noshuyo Byori; 1996 Apr; 13(1):73-8. PubMed ID: 8916130
[TBL] [Abstract][Full Text] [Related]
16. Subependymomas: clinicopathologic study of 14 tumors, including comparative MIB-1 immunohistochemical analysis with other ependymal neoplasms.
Prayson RA; Suh JH
Arch Pathol Lab Med; 1999 Apr; 123(4):306-9. PubMed ID: 10320142
[TBL] [Abstract][Full Text] [Related]
17. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information.
Fetsch JF; Laskin WB; Hallman JR; Lupton GP; Miettinen M
Am J Surg Pathol; 2007 Jul; 31(7):1103-14. PubMed ID: 17592278
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
19. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
Machen SK; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
